80 studies found for:    Open Studies | "Bone Diseases, Infectious"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Bone Diseases, Infectious" (80 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis
Condition: Tuberculosis, Spinal
Interventions: Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide
2 Not yet recruiting Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Condition: Ankylosing Spondylitis
Interventions: Drug: NSAIDs;   Drug: anti-TNF
3 Not yet recruiting Phenomics in Autoimmune and Inflammatory Diseases
Conditions: Healthy Volunteer;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus/Antiphospholipid Syndrome;   FMF;   Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome;   Vasculitis;   Uveitis;   Myositis;   Crohn's Disease;   Ulcerative Rectocolitis;   Type 1 Diabetes;   Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy
Interventions: Other: 1: AID groups;   Other: 2: Control groups
4 Recruiting UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository
Conditions: Diabetic Foot Ulcers;   Osteomyelitis
Intervention: Other: DFU
5 Recruiting Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: TNF alpha;   Drug: NSAIDs and sulfasalazine
6 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
7 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Naive Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
8 Not yet recruiting An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Condition: Nonradiographic Axial Spondylitis, Ankylosing
Interventions: Drug: Group 1: Placebo;   Drug: Group 2: Ustekinumab 45 mg;   Drug: Group 3: Ustekinumab 90 mg
9 Not yet recruiting The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
Conditions: Inflammatory Bowel Diseases;   Ankylosing Spondylitis
Interventions: Procedure: Pinch biopsies;   Procedure: Flexible sigmoidoscopy
10 Recruiting Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction
Condition: Alveolar Osteitis
Interventions: Drug: DC071;   Drug: Placebo
11 Recruiting COMorbidities and EDucation in SPondyloArthritis Study
Condition: Axial Spondyloarthritis
Interventions: Behavioral: self-assessment/self-management;   Behavioral: Comorbidities (detection/prevention)
12 Recruiting Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein
Condition: Spondyloarthritis
Interventions: Drug: etanercept;   Drug: etanercept (half dose);   Drug: placebo
13 Recruiting Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Infliximab (BCD-055);   Drug: Infliximab (Remicade)
14 Not yet recruiting The Effect of Exercise on Disease Activity and Cardiovascular Risk for Patients With Axial SpondyloArthritis
Condition: Axial Spondyloarthritis
Intervention: Behavioral: Exercise
15 Recruiting A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life
Condition: Axial Spondyloarthritis
Intervention:
16 Not yet recruiting Phase 3, Multicenter, Doubleblind, Rand Dalbavancin vs Comparator in Ped Acute Hematogenous Osteomyelitis
Condition: Osteomyelitis
Interventions: Drug: Dalbavancin;   Drug: cefazolin, nafcillin, oxacillin or vancomycin
17 Recruiting Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
Conditions: Hematogenously Acquired Stapylococcus Aureus Osteomyelitis;   Bone Infection;   Osteomyelitis
Intervention: Drug: Ceftaroline Fosamil
18 Recruiting Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients
Condition: Ankylosing Spondylitis
Intervention:
19 Recruiting 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis
Intervention: Drug: 99mTc-rhAnnexin V-128
20 Not yet recruiting Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression
Condition: Ankylosing Spondylitis
Interventions: Drug: Pamidronate;   Other: Placebo (NaCl 0.9%)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years